Arca Biopharma | ABIO - Current Liabilities


Arca Biopharma reported $15.37M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Arca Biopharma USD 15.37M 5.59M Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Brainstorm Cell Therapeutics USD 11.01M 1.98M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
Otsuka Holdings JPY 749.11B 50.84B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
United Therapeutics USD 560.6M 14.3M Dec/2025